Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy

References

• DrukerBGuilhotFO’BrianSFive-year follow-up of patients receiving imatinib for chronic myeloid leukemiaN Engl J Med20063552408241717151364
   PubMed Web of Science ®Google Scholar
• GoldenbergMMTrastuzumab, a recombinant DNA derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancerClin Ther1999230931810211534
   PubMed Web of Science ®Google Scholar
• PetersonCDrug therapy of cancerEur J Clin Pharmacol20116743744721336995
   PubMed Web of Science ®Google Scholar
• GilbertWThe RNA worldNature1986319216
   Web of Science ®Google Scholar
• FireAXuSMontgomeryMKKostasSADriverSEMelloCCPotent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature19983918068119486653
   PubMed Web of Science ®Google Scholar
• ElbashirSMHarborthJLendeckelWYalcinAWeberKTuschlTDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature200141149449811373684
   PubMed Web of Science ®Google Scholar
• McCaffreyAPMeuseLPhamTTConklinDSHannonGJKayMAGene expression: RNA interference in adult miceNature2002418383912097900
   PubMed Web of Science ®Google Scholar
• WallNRShiYSmall RNA: can RNA interference be exploited for therapy?Lancet20033621401140314585643
   PubMed Web of Science ®Google Scholar
• DeviGRsiRNA-based approaches in cancer therapyCancer Gene Ther20061381982916424918
   PubMed Web of Science ®Google Scholar
• AbdelrahimMSafeSBakerCAbudayyehCRNAi and cancer: implications and applicationsJ RNAi Gene Silencing2006213614519771215
   PubMedGoogle Scholar
• GartelALKandelESRNA interference in cancerBiomol Eng200623173416466964
   PubMedGoogle Scholar
• GrimmDKayMARNAi and gene therapy: a mutual attractionHematol Am Soc Hematol Educ Program2007473481
   PubMedGoogle Scholar
• DeVincenzoJLambkin-WilliamsRWilkinsonTA randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virusProc Natl Acad Sci U S A20101078800880520421463
   PubMed Web of Science ®Google Scholar
• SubramanyaSKimSSManjunathNShankarPRNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA?Expert Opin Biol Ther2010220121320088715
   PubMed Web of Science ®Google Scholar
• ChenYChengGMahatoRIRNAi for treating hepatitis B viral infectionPharm Res20081728618074201
   PubMed Web of Science ®Google Scholar
• AshfaqUAYousafMZAslamMEjazRJahanSUllahOsiRNAs: potential therapeutic agents against hepatitis C virusVirol J2011827621645341
   PubMed Web of Science ®Google Scholar
• MorrisseyDVLockridgeJAShawLPotent and persistent in vivo anti-HBV activity of chemically modified siRNAsNat Biotechnol2005231002100716041363
   PubMed Web of Science ®Google Scholar
• DiFigliaMSena-EstevesMChaseKTherapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficitsProc Natl Acad Sci U S A2007104172041720917940007
   PubMed Web of Science ®Google Scholar
• FarahMHRNAi silencing in mouse models of neurodegenerative diseasesCurr Drug Deliv2007416116717456035
   PubMedGoogle Scholar
• LiTKoshySFolkessonHGRNA interference for CFTR attenuates lung fluid absorption at birth in ratsRespir Res200895518652671
   PubMed Web of Science ®Google Scholar
• CourtiesGPresumeyJDuroux-RichardIJorgensenCApparaillyFRNA interference-based gene therapy for successful treatment of rheumatoid arthritisExpert Opin Biol Ther2009953553819392574
   PubMed Web of Science ®Google Scholar
• MartinezLANaguibnevaILehrmannHSynthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathwaysProc Natl Acad Sci U S A200299148491485412403821
   PubMed Web of Science ®Google Scholar
• PaiSILinYYMacaesBMeneshianAHungCFWuTCProspects of RNA interference therapy for cancerGene Ther20061346447716341059
   PubMed Web of Science ®Google Scholar
• TakeshitaTOchiyaTTherapeutic potential of RNA interference against cancerCancer Sci20069768969616863503
   PubMed Web of Science ®Google Scholar
• WhelanJFirst clinical data on RNAiDrug Discov Today2005101014101516055013
   PubMed Web of Science ®Google Scholar
• CastanottoDRossiJJThe promises and pitfalls of RNA-interference-based therapeuticsNature200945742643319158789
   PubMed Web of Science ®Google Scholar
• PecotCVCalinGAColemanRLLopez-BeresteinGSoodAKRNA interference in the clinic: challenges and future directionsNat Rev Cancer201111596721160526
   PubMed Web of Science ®Google Scholar
• DavisMEZuckermanJEChoiCHEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature20104641067107020305636
   PubMed Web of Science ®Google Scholar
• HammondSMDicing and slicing the core machinery of the RNA interference pathwayFEBS Lett20055795822582916214139
   PubMed Web of Science ®Google Scholar
• MatrangaCTomariYShinCBartelDPZamorePDPassenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexesCell200512360762016271386
   PubMed Web of Science ®Google Scholar
• ToliaNHJoshua-TorLSlicer and the ArgonautesNat Chem Biol20073364317173028
   PubMed Web of Science ®Google Scholar
• AmeresSLMartinezJSchroederRMolecular basis for target RNA recognition and cleavage by human RISCCell200713010111217632058
   PubMed Web of Science ®Google Scholar
• RandTAPetersenSDuFWangXArgonaute2 cleaves the anti-guide strand of siRNA during RISC activationCell200512362162916271385
   PubMed Web of Science ®Google Scholar
• DykxhoornDMLiebermanJKnocking down disease with siRNAsCell200612623123516873051
   PubMed Web of Science ®Google Scholar
• NovinaCDSharpPAThe RNAi revolutionNature200443016116415241403
   PubMed Web of Science ®Google Scholar
• LingelASattlerMNovel modes of protein-RNA recognition in the RNAi pathwayCurr Opin Struct Biol20051510711515718141
   PubMed Web of Science ®Google Scholar
• BartlettDWDavisMEInsights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imagingNucleic Acids Res20063432233316410612
   PubMed Web of Science ®Google Scholar
• GarzonRMarcucciGCroceCMTargeting microRNAs in cancer: rationale, strategies and challengesNat Rev Drug Discov2010977578920885409
   PubMed Web of Science ®Google Scholar
• BrummelkampTRBernardsRAgamiRA system for stable expression of short interfering RNAs in mammalian cellsScience200229655055311910072
   PubMed Web of Science ®Google Scholar
• RötherSMeisterGSmall RNAs derived from longer non-coding RNAsBiochimie2011931905191521843590
   PubMed Web of Science ®Google Scholar
• GhildiyalMZamorePDSmall silencing RNAs: an expanding universeNat Rev Genet2009109410819148191
   PubMed Web of Science ®Google Scholar
• YuBZhaoXLeeLJLeeRJTargeted delivery Systems for oligonucleotide therapeuticsAAPS J20091119520319296227
   PubMed Web of Science ®Google Scholar
• ChenSHZhaoriGPotential clinical applications of siRNA technique: benefits and limitationsEur J Clin Invest20114122123220964680
   PubMed Web of Science ®Google Scholar
• MasieroMNardoGIndraccoloSFavaroERNA interference: implications for cancer treatmentMol Aspects Med2007114316617307250
   PubMed Web of Science ®Google Scholar
• BakerMHoming in on deliveryNature201046212251228
   Web of Science ®Google Scholar
• De SmaeleEFerrettiEGulinoAMicroRNAs as biomarkers for CNS cancer and other disordersBrain Res2010133810011120380821
   PubMed Web of Science ®Google Scholar
• AagaardLRossiJJRNAi therapeutics: principles, prospects and challengesAdv Drug Deliv Rev200759758617449137
   PubMed Web of Science ®Google Scholar
• ZhaoXPanFHoltCMLewisALLuJRControlled delivery of antisense oligonucleotides: a brief review of current strategiesExpert Opin Drug Deliv2009667368619552611
   PubMed Web of Science ®Google Scholar
• BumcrotDManoharanMKotelianskyVSahDWYRNAi therapeutics: a potential new class of pharmaceutical drugsNat Chem Biol2006271171917108989
   PubMed Web of Science ®Google Scholar
• WhiteheadKALangerRAndersonDGKnocking down barriers: advances in siRNA deliveryNat Rev Drug Discov2009212913819180106
   PubMed Web of Science ®Google Scholar
• KimDHRossiJJStrategies for silencing human disease using RNA interferenceNat Rev Genet2007317318417304245
   PubMed Web of Science ®Google Scholar
• HeidelJDYuZLiuJYAdministration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunitM2 siRNAProc Natl Acad Sci U S A20071045715572117379663
   PubMed Web of Science ®Google Scholar
• DesaiAASchilskyRLYoungAA phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumorsAnn Oncol2005695896515824081
   PubMed Web of Science ®Google Scholar
• GrimmDStreetzKLJoplingCLFatality in mice due to over-saturation of cellular microRNA/short hairpin RNA pathwaysNature200644153754116724069
   PubMed Web of Science ®Google Scholar
• CastanottoDSakuraiKLingemanRCombinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISCNucleic Acids Res2007355154516417660190
   PubMed Web of Science ®Google Scholar
• HornungVGuenthner-BillerMBourquinCSequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7Nat Med20051126327015723075
   PubMed Web of Science ®Google Scholar
• JudgeADSoodVShawJRFangDMcClintockKMacLachlanISequence-dependent stimulation of the mammalian innate immune response by synthetic siRNANat Biotechnol20052345746215778705
   PubMed Web of Science ®Google Scholar
• GantierMPWilliamsBRThe response of mammalian cells to double-stranded RNACytokine Growth Factor Rev20071836337117698400
   PubMed Web of Science ®Google Scholar
• KleinmanMEYamadaKTakedaASequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature200845259159718368052
   PubMed Web of Science ®Google Scholar
• JacksonALBartzSRSchelterJExpression profiling reveals off-target gene regulation by RNAiNat Biotechnol20032163563712754523
   PubMed Web of Science ®Google Scholar
• JacksonALBurchardJSchelterJWidespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarityRNA2006121179118716682560
   PubMed Web of Science ®Google Scholar
• DiasNSteinCAAntisense oligonucleotides: basic concepts and mechanismsMol Cancer Ther2002134735512489851
   PubMed Web of Science ®Google Scholar
• OliveiraSvan RooyIKranenburgOStormGSchiffelersRFusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenesInt J Pharm200733121121417187949
   PubMed Web of Science ®Google Scholar
• SchroederALevinsCGCortezCLangerRAndersonDGLipid-based nanotherapeutics for siRNA deliveryJ Intern Med201026792120059641
   PubMed Web of Science ®Google Scholar
• MieleESpinelliGPMieleETomaoFTomaoSAlbumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancerInt J Nanomedicine200949910519516888
   PubMed Web of Science ®Google Scholar
• De AngelisFGentileFMecariniFBreaking the diffusion limit with super-hydrophobic delivery of molecules to plasmonic nanofocusing SERS structuresNat Photonics20115682687
   Web of Science ®Google Scholar
• PujiaADe AngelisFScumaciDHighly efficient human serum filtration with water-soluble nanoporous nanoparticlesInt J Nanomedicine201051005101521187942
   PubMed Web of Science ®Google Scholar
• FarokhzadOCLangerRImpact of nanotechnology on drug deliveryACS Nano20093162019206243
   PubMed Web of Science ®Google Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer200556171
   Web of Science ®Google Scholar
• WongMSNanoparticles and catalysisAstrucDidierAngewandte Chemie International EditionWeindham, GermanyWiley2008
   Google Scholar
• KnöpfelTAkemannWNanobiotechnology: remote control of cellsNat Nanotechnol20108560561
   Google Scholar
• MichaletXPinaudFFBentolilaLAQuantum dots for live cells, in vivo imaging, and diagnosticsScience200530753854415681376
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm2008550551518672949
   PubMed Web of Science ®Google Scholar
• GlassGPharmaceutical patent challenges – time for reassessment?Nat Rev Drug Discov200431057106215573104
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNanocarrier as an emerging platform for cancer therapyNat Nanotechnol2007275176018654426
   PubMed Web of Science ®Google Scholar
• WeislederRKimberlyKYi SunEShtalandTJosephsonLCell-specific targeting of nanoparticles by multivalent attachment of small moleculesNat Biotechnol2005231418142316244656
   PubMed Web of Science ®Google Scholar
• ByrneJDBetancourtTBrannon-PeppasLActive targeting schemes for nanoparticle systems in cancer therapeuticsAdv Drug Deliv Rev2008601615162618840489
   PubMed Web of Science ®Google Scholar
• ParkJi-HoGuLvon MaltzahnGRuoslahtiEBhatiaSNSailorMJBiodegradable luminescent porous silicon nanoparticles for in vivo applicationsNat Mater2009833133619234444
   PubMed Web of Science ®Google Scholar
• JanibSMMosesASMacKayJAImaging and drug delivery using theranostic nanoparticlesAdv Drug Deliv Rev2010621052106320709124
   PubMed Web of Science ®Google Scholar
• TasciottiELiuXBhavaneRMesoporous silicon particles as a multistage delivery system for imaging and therapeutic applicationNat Nanotechnol20083152157
   Web of Science ®Google Scholar
• ChanJMZhangLTongSpatiotemporal controlled delivery of nanoparticles to injured vasculatureProc Natl Acad Sci U S A20101072213221820133865
   PubMed Web of Science ®Google Scholar
• SenguptaSEavaroneDCapilaITemporal targeting of tumor cells and neovasculature with a nanoscale delivery systemNature200543656857216049491
   PubMed Web of Science ®Google Scholar
• BigallNCCurcioAPernia LealMPMagnetic nanocarriers with tunable pH dependence for controlled loading and release of cationic and anionic payloadsAdv Mater2011235645565022095932
   PubMed Web of Science ®Google Scholar
• WaehlerRRussellSJCurielDTEngineering targeted viral vectors for gene therapyNat Rev Genet2007857358717607305
   PubMed Web of Science ®Google Scholar
• MintzerMASimanekEENonviral vectors for gene deliveryChem Rev200910925930219053809
   PubMed Web of Science ®Google Scholar
• GaoYLiuXLLiXRResearch progress on siRNA delivery with nonviral carriersInt J Nanomedicine201161017102521720513
   PubMed Web of Science ®Google Scholar
• KimWJKimSWEfficient siRNA delivery with non-viral polymeric vehiclesPharm Res20092665766619015957
   PubMed Web of Science ®Google Scholar
• SchaffertDWagnerEGene therapy progress and prospects: synthetic polymer-based systemsGene Ther2008151131113818528432
   PubMed Web of Science ®Google Scholar
• TokatlianTSeguraTsiRNA applications in nanomedicineNanomed Nanobiotechnol20102305315
   Web of Science ®Google Scholar
• ChiuYLRanaTMsiRNA function in RNAi: a chemical modification analysisRNA200391034104812923253
   PubMed Web of Science ®Google Scholar
• BehlkeMAProgress towards in vivo use of siRNAsMol Ther20061364467016481219
   PubMed Web of Science ®Google Scholar
• MalikRRoyLDesign and development of antisense drugsExp Opin Drug Discov2008311891207
   PubMed Web of Science ®Google Scholar
• ChiarantiniLCerasiAFraternaleAComparison of a novel delivery system for antisense peptide nucleid acidsJ Control Release2005109243616290244
   PubMed Web of Science ®Google Scholar
• SoutschekJAkincABramlageBTherapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature200443217317815538359
   PubMed Web of Science ®Google Scholar
• RaalFDSantosRDBlomDJMipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialLancet2010375998100620227758
   PubMed Web of Science ®Google Scholar
• ZhaoXLiHLeeJRTargeted drug delivery via folate receptorsExpert Opin Drug Deliv2008530931918318652
   PubMed Web of Science ®Google Scholar
• Hu-LieskovanSHeidelJDBartlettDWDavisMETricheTJSequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing’s sarcomaCancer Res2005658984899216204072
   PubMed Web of Science ®Google Scholar
• SongEZhuPLeeSKAntibody mediated in vivo delivery of small interfering RNAs via cell-surface receptorsNat Biotechnol20052370971715908939
   PubMed Web of Science ®Google Scholar
• McNamaraJO2ndAndrechekERWangYCell type-specific delivery of siRNAs with aptamer-siRNA chimerasNat Biotechnol2006241005101516823371
   PubMed Web of Science ®Google Scholar
• MuratovskaAEcclesMRConjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cellsFEBS Lett2004558636814759517
   PubMed Web of Science ®Google Scholar
• HatakeyamaHItoEAkitaHA pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivoJ Control Release200913912713219540888
   PubMed Web of Science ®Google Scholar
• BartlettDWSuHHildebrandtIJWeberWADavisMEImpact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProc Natl Acad Sci U S A2007104155491555417875985
   PubMed Web of Science ®Google Scholar
• PirolloKFChangEHTargeted delivery of small interfering RNA: approaching effective cancer therapiesCancer Res2008681247125018316585
   PubMed Web of Science ®Google Scholar
• LeeHMokHLeeSOhYKParkTGTarget specific intracellular delivery of siRNA using degradable hyaluronic acid nanogelsJ Control Release200711924525217408798
   PubMed Web of Science ®Google Scholar
• RozemaDBLewisDLWakefieldDHDynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytesProc Natl Acad Sci U S A2007104129821298717652171
   PubMed Web of Science ®Google Scholar
• ZuhornISEngbertsJBHoeckstraDGene delivery by cationic lipid vectors: overcoming cellular barriersEur Biophys J20073634936217019592
   PubMed Web of Science ®Google Scholar
• ChirilaTVRakoczyPEGarrettKLLouXConstableIJThe use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotidesBiomaterials20022332134211761152
   PubMed Web of Science ®Google Scholar
• RosiNLGiljohannDAThaxtonCSLytton-JeanAKHanMSMirkinCAOligonucleotide-modified gold nanoparticles for intracellular gene regulationScience20063121027103016709779
   PubMed Web of Science ®Google Scholar
• ConvertineAJBenoitDSDuvallCLHoffmanASStaytonPSDevelopment of a novel endosomolytic diblock copolymer for siRNA deliveryJ Control Release200913322122918973780
   PubMed Web of Science ®Google Scholar
• WagnerEPolymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and preciseAcc Chem Res20112210.1021/ar2002232
   Web of Science ®Google Scholar
• Urban-KleinBWerthSAbuharbeidSCzubaykoFAignerARNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivoGene Ther20051246146615616603
   PubMed Web of Science ®Google Scholar
• OhYKParkTGsiRNA delivery systems for cancer treatmentAdv Drug Deliv Rev20096185086219422869
   PubMed Web of Science ®Google Scholar
• NimeshSGuptaNChandraRCationic polymer based nanocarriers for delivery of therapeutic nucleic acidsJ Biomed Nanotechnol2011750452021870455
   PubMed Web of Science ®Google Scholar
• SinghaKNamgungRKimWJPolymers in small-interfering RNA deliveryNucleic Acid Ther20112113314721749290
   PubMed Web of Science ®Google Scholar
• TroiberCWagnerENucleic acid carriers based on precise polymer conjugatesBioconjug Chem2011221737175221749135
   PubMed Web of Science ®Google Scholar
• DuncanRPolymer therapeutics as nanomedicines: new perspectivesCurr Opin Biotechnol20112249250121676609
   PubMed Web of Science ®Google Scholar
• SempleSCAkincAChenJRational design of cationic lipids for siRNA deliveryNat Biotechnol20102817217620081866
   PubMed Web of Science ®Google Scholar
• GuoPCobanOSneadNMEngineering RNA for targeted siRNA delivery and medical applicationAdv Drug Deliv Rev20106265066620230868
   PubMed Web of Science ®Google Scholar
• MerrittWMLinYGSpannuthWAEffect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growthJ Natl Cancer Inst200810035937218314475
   PubMed Web of Science ®Google Scholar
• LandenCNJrChavez-ReyesABucanaCTherapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA deliveryCancer Res2005656910691816061675
   PubMed Web of Science ®Google Scholar
• DharmapuriSPeruzziDMarraEIntratumor RNA interference of cell cycle genes slows down tumor progressionGene Ther20111872773321390070
   PubMed Web of Science ®Google Scholar
• MaZLiJHeFWilsonAPittBLiSCationic lipids enhance siRNA-mediated interferon response in miceBiochem Biophys Res Commun200533075575915809061
   PubMed Web of Science ®Google Scholar
• DokkaSToledoDShiXCastranovaVRojanasakulYOxygen radical-mediated pulmonary toxicity induced by some cationic liposomesPharm Res2000175215252155
   Web of Science ®Google Scholar
• MehnertWMäderKSolid lipid nanoparticles: production, characterization and applicationsAdv Drug Deliv Rev20014716519611311991
   PubMed Web of Science ®Google Scholar
• GallarateMBattagliaLPeiraETrottaMPeptide-loaded solid lipid nanoparticles prepared through coacervation techniqueInternational Journal of Chemical Engineering201116
   Google Scholar
• GeisbertTWLeeACRobbinsMPostexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept studyLancet20103751896190520511019
   PubMed Web of Science ®Google Scholar
• LobovkinaTJacobsonGBGonzalez-GonzalezEIn vivo sustained release of siRNA from solid lipid nanoparticlesACS Nano201159977998322077198
   PubMed Web of Science ®Google Scholar
• KimSHJeongJHLeeSHKimSWParkTGPEG conjugated VEGF siRNA for anti-angiogenic gene therapyJ Control Release20061161239
   Web of Science ®Google Scholar
• BoussifOLezoualc’hFZantaMAA versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimineProc Natl Acad Sci U S A199592729773017638184
   PubMed Web of Science ®Google Scholar
• ZimmermannTSLeeACHAkincARNAi-mediated gene silencing in non-human primatesNature200644111111416565705
   PubMed Web of Science ®Google Scholar
• AkincAGoldbergMQinJDevelopment of lipidoid-siRNA formulations for systemic delivery to the liverMol Ther20091787287919259063
   PubMed Web of Science ®Google Scholar
• AkincAZumbuehlAGoldbergMA combinatorial library of lipid-like materials for delivery of RNAi therapeuticsNat Biotechnol20082656156918438401
   PubMed Web of Science ®Google Scholar
• VaishnawAKGollobJGamba-VitaloCA status report on RNAi therapeuticsSilence201011420615220
   PubMedGoogle Scholar
• ChenAADerfusAMKhetaniSRBhatiaSNQuantum dots to monitor RNAi delivery and improve gene silencingNucleic Acids Res20053319015647502
   PubMed Web of Science ®Google Scholar
• GaoXCuiYLevensonRMChungLWKNie1SIn vivo cancer targeting and imaging with semiconductor quantum dotsNat Biotechnol20042296997615258594
   PubMed Web of Science ®Google Scholar
• YezhelyevMVQiLO’ReganRMNieSGaoXProton-sponge coated quantum dots for siRNA delivery and intracellular imagingJ Am Chem Soc20081309006901218570415
   PubMed Web of Science ®Google Scholar
• OishiMNakaogamiJIshiiTNagasakiYSmart PEGylated gold nanoparticles for the cytoplasmic delivery of siRNA to induce enhanced gene silencing ChemLett20063510461047
   Google Scholar
• ElbakryAZakyALieblRRachelRGoepferichABreunigMLayer-by-layer assembled gold nanoparticles for siRNA deliveryNano Lett200952059206419331425
   PubMed Web of Science ®Google Scholar
• LeeJSGreenJJLoveKTSunshineJLangerRAndersonDGGold, poly(beta-amino ester) nanoparticles for small interfering RNA deliveryNano Lett200962402240619422265
   PubMed Web of Science ®Google Scholar
• Lytton-JeanALangerRAndersonDGFive years of siRNA delivery: spotlight on gold nanoparticlesSmall201171932193721681985
   PubMed Web of Science ®Google Scholar
• MedarovaZPhamWFarrarCPetkovaVMooreAIn vivo imaging of siRNA delivery and silencing in tumorsNat Med2007337237717322898
   PubMed Web of Science ®Google Scholar
• CurcioAMarottaRRiedingerAPalumberiDFalquiAPellegrinoTMagnetic pH-responsive nanogels as multifunctional delivery tools for small interfering RNA (siRNA) and iron oxide nanoparticles (IONPs)Chem Commun (Camb)2012482400240222266784
   PubMed Web of Science ®Google Scholar
• XiaTKovochichMLiongMPolyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructsACS Nano200933273328619739605
   PubMed Web of Science ®Google Scholar
• TanakaTMangalaLSVivas-MejiaPESustained small interfering RNA delivery by mesoporous silicon particlesCancer Res2010703687369620430760
   PubMed Web of Science ®Google Scholar
• KamNWLiuZDaiHFunctionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencingJ Am Chem Soc2005127124921249316144388
   PubMed Web of Science ®Google Scholar
• LeeSYangSCKaoCYPierceRHMurthyNSolid polymeric microparticles enhance the delivery of siRNA to macrophages in vivoNucleic Acids Res200937145
   PubMed Web of Science ®Google Scholar
• JacobsonGBShindeRMcCulloughRLNanoparticle formation of organic compounds with retained biological activityJ Pharm Sci2010992750275520039390
   PubMed Web of Science ®Google Scholar
• KrebsMDJeonOAlsbergELocalized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogelsJ Am Chem Soc20091319204920619530653
   PubMed Web of Science ®Google Scholar
• PatilYPanyamJPolymeric nanoparticles for siRNA delivery and gene silencingInt J Pharm200936719520318940242
   PubMed Web of Science ®Google Scholar
• YagiNManabeITottoriTA nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivoCancer Res2009696531653819654315
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov2010961562720616808
   PubMed Web of Science ®Google Scholar
• LongmireMChoykePLKobayashiHClearance properties of nanosized particles and molecules as imaging agents: considerations and caveatsNanomedicine (Lond)2008570371718817471
   PubMed Web of Science ®Google Scholar
• DecuzziPCausaFFerrariMNettiPAThe effective dispersion of nanovectors within the tumor microvasculatureAnn Biomed Eng2006463364116568349
   PubMed Web of Science ®Google Scholar
• LiLWilcoxDZhaoXTumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA deliveryGene Ther201116
   Web of Science ®Google Scholar
• DominskaMDykxhoornDMBreaking down the barriers: siRNA delivery and endosome escapeJ Cell Sci20101231183118920356929
   PubMed Web of Science ®Google Scholar
• DobrovolskaiaMAAggarwalPHallJBMcNeilSEPreclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistributionMol Pharm2008448749518510338
   PubMed Web of Science ®Google Scholar
• SeyhanAARNAi: a potential new class of therapeutic for human genetic diseaseHum Genet201113058360521537948
   PubMed Web of Science ®Google Scholar
• DavidsonBLMcCrayPBCurrent prospects for RNA interference-based therapiesNat Rev Genet20111232934021499294
   PubMed Web of Science ®Google Scholar
• Alnylam PharmaceuticalsAlnylam achieves first human proof of concept for an RNAi therapeutic with GEMINI study Available from: http://www.alnylam.com/Programs-and-Pipeline/Partner-Programs/index.php. Accessed April 17, 2012.
   Google Scholar
• LeachmanSAHickersonRPHullPRTherapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenitaJ Dermatol Sci20085115115718495438
   PubMed Web of Science ®Google Scholar
• LeachmanSAHickersonRPSchwarzMEFirst-in-human mutation targeted siRNA phase Ib trial of an inherited skin disorderMol Ther20101844244619935778
   PubMed Web of Science ®Google Scholar
• GondiCRaoJSConcepts in in-vivo siRNA delivery for cancer therapyJ Cell Physiol200922028529119391103
   PubMed Web of Science ®Google Scholar
• PtasznikANakataYKalotaAEmersonSGGewirtzAMShort interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug resistant, BCR-ABL1+ leukemia cellsNat Med2004101187118915502840
   PubMed Web of Science ®Google Scholar
• KoldehoffMSteckelNKBeelenDWElmaagacliAHTherapeutic application of small interfering RNA directed against bcr-abl transcripts to a patient with imatinib-resistant chronic myeloid leukaemiaClin Exp Med20077475517609876
   PubMed Web of Science ®Google Scholar
• ShimMSKwonYJEfficient and targeted delivery of siRNA in-vivoFEBS J20102774814481721078116
   PubMed Web of Science ®Google Scholar
• VaccariLCantonDZaffaroniNPorous silicon as drug carrier for controlled delivery of doxorubicin anticancer agentMicr Eng20068315981601
   Web of Science ®Google Scholar
• GentileFTirinatoLBattistaECells preferentially grow on rough substratesBiomaterials2010317205721220637503
   PubMed Web of Science ®Google Scholar
• GaspariMMing-Cheng ChengMTerraccianoRNanoporous surfaces as harvesting agents for mass spectrometric analysis of peptides in human plasmaJ Proteome Res200651261126616674117
   PubMed Web of Science ®Google Scholar